BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Chen W, Ou M, Tang D, Dai Y, Du W. Identification and Validation of Immune-Related Gene Prognostic Signature for Hepatocellular Carcinoma. J Immunol Res 2020;2020:5494858. [PMID: 32211443 DOI: 10.1155/2020/5494858] [Cited by in Crossref: 25] [Cited by in F6Publishing: 31] [Article Influence: 12.5] [Reference Citation Analysis]
Number Citing Articles
1 Long M, Zhou Z, Wei X, Lin Q, Qiu M, Zhou Y, Chen P, Jiang Y, Wen Q, Liu Y, Li R, Zhou X, Yu H. A novel risk score based on immune-related genes for hepatocellular carcinoma as a reliable prognostic biomarker and correlated with immune infiltration. Front Immunol 2022;13. [DOI: 10.3389/fimmu.2022.1023349] [Reference Citation Analysis]
2 Wang Y, Feng J, Liu Y, Han T, Huang T. A Risk-Assessing Signature Based on Hypoxia- and Immune-Related Genes for Prognosis of Lung Adenocarcinoma Patients. Computational and Mathematical Methods in Medicine 2022;2022:1-13. [DOI: 10.1155/2022/7165851] [Reference Citation Analysis]
3 Zhang C, Yang Y, Wang K, Chen M, Lu M, Hu C, Du X, Xing B, Liu X, Zhang J. The Systematic Analyses of RING Finger Gene Signature for Predicting the Prognosis of Patients with Hepatocellular Carcinoma. Journal of Oncology 2022;2022:1-17. [DOI: 10.1155/2022/2466006] [Reference Citation Analysis]
4 Peng Q, Huang H, Zhu C, Hou Q, Wei S, Xiao Y, Zhang Z, Sun X, Ali Sheikh MS. CDC20 May Serve as a Potential Biomarker-Based Risk Score System in Predicting the Prognosis of Patients with Hepatocellular Carcinoma. Oxidative Medicine and Cellular Longevity 2022;2022:1-21. [DOI: 10.1155/2022/8421813] [Reference Citation Analysis]
5 Wang S, Cheng L, Jing F, Li G. Screening and identification of immune-related genes for immunotherapy and prognostic assessment in colorectal cancer patients. BMC Med Genomics 2022;15:177. [PMID: 35941638 DOI: 10.1186/s12920-022-01329-2] [Reference Citation Analysis]
6 Qian B, Lin H, Lan T, Li M, Wu X, Lin S, Song Z, Shen S, Peng B. Risk predictive model based on three immune-related gene pairs to assess prognosis and therapeutic sensitivity for hepatocellular carcinoma. World J Surg Oncol 2022;20:252. [PMID: 35932027 DOI: 10.1186/s12957-022-02681-4] [Reference Citation Analysis]
7 Cai Q, Duan J, Ding L. Prognostic model of immune-related genes for patients with hepatocellular carcinoma. Front Surg 2022;9. [DOI: 10.3389/fsurg.2022.819491] [Reference Citation Analysis]
8 Gao X, Wang WX, Zhang XL. A novel pyroptosis risk model composed of NLRP6 effectively predicts the prognosis of hepatocellular carcinoma patients. Cancer Med 2022. [PMID: 35651286 DOI: 10.1002/cam4.4898] [Reference Citation Analysis]
9 Liu Y, Xu L, Hao C, Wu J, Jia X, Ding X, Lin C, Zhu H, Zhang Y. Identification and Validation of Novel Immune-Related Alternative Splicing Signatures as a Prognostic Model for Colon Cancer. Front Oncol 2022;12:866289. [DOI: 10.3389/fonc.2022.866289] [Reference Citation Analysis]
10 Wang ZZ, Meng T, Yang MY, Wang W, Zhang Y, Liu Y, Han AQ, Wu J, Wang HX, Qian B, Zhu LX. ALYREF associated with immune infiltration is a prognostic biomarker in hepatocellular carcinoma. Transl Oncol 2022;21:101441. [PMID: 35523010 DOI: 10.1016/j.tranon.2022.101441] [Reference Citation Analysis]
11 Liu J, Gu L, Zhang D, Li W. Determining the Prognostic Value of Spliceosome-Related Genes in Hepatocellular Carcinoma Patients. Front Mol Biosci 2022;9:759792. [DOI: 10.3389/fmolb.2022.759792] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Zeng Z, Gao Y, Li J, Zhang G, Sun S, Wu Q, Gong Y, Xie C. Violations of proportional hazard assumption in Cox regression model of transcriptomic data in TCGA pan-cancer cohorts. Comput Struct Biotechnol J 2022;20:496-507. [PMID: 35070171 DOI: 10.1016/j.csbj.2022.01.004] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
13 Xu F, Chen J, Huang D. Pan-cancer analysis identifies FAM49B as an immune-related prognostic maker for hepatocellular carcinoma. J Cancer 2022;13:278-89. [PMID: 34976189 DOI: 10.7150/jca.65421] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Zhang X, Ping S, Wang A, Li C, Zhang R, Song Z, Gao C, Wang F. Development and Validation of an Immune-Related Gene Pairs Signature in Grade II/III Glioma. Int J Gen Med 2021;14:8611-20. [PMID: 34849006 DOI: 10.2147/IJGM.S335052] [Reference Citation Analysis]
15 Qin P, Zhang M, Liu X, Dong Z. Immunogenomic Landscape Analysis of Prognostic Immune-Related Genes in Hepatocellular Carcinoma. J Healthc Eng 2021;2021:3761858. [PMID: 34745496 DOI: 10.1155/2021/3761858] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
16 Lin Z, Xie YZ, Zhao MC, Hou PP, Tang J, Chen GL. Xanthine dehydrogenase as a prognostic biomarker related to tumor immunology in hepatocellular carcinoma. Cancer Cell Int 2021;21:475. [PMID: 34496841 DOI: 10.1186/s12935-021-02173-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
17 Gao X, Zhao C, Zhang N, Cui X, Ren Y, Su C, Wu S, Yao Z, Yang J. Genetic expression and mutational profile analysis in different pathologic stages of hepatocellular carcinoma patients. BMC Cancer 2021;21:786. [PMID: 34238242 DOI: 10.1186/s12885-021-08442-y] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
18 Wang J, Han K, Zhang C, Chen X, Li Y, Zhu L, Luo T. Identification and validation of ADME genes as prognosis and therapy markers for hepatocellular carcinoma patients. Biosci Rep 2021;41:BSR20210583. [PMID: 33988674 DOI: 10.1042/BSR20210583] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
19 Pan X, Wang Z, Liu F, Zou F, Xie Q, Guo Y, Shen L. A novel tailored immune gene pairs signature for overall survival prediction in lower-grade gliomas. Transl Oncol 2021;14:101109. [PMID: 33946034 DOI: 10.1016/j.tranon.2021.101109] [Reference Citation Analysis]
20 Tu Z, He X, Zeng L, Meng D, Zhuang R, Zhao J, Dai W. Exploration of Prognostic Biomarkers for Lung Adenocarcinoma Through Bioinformatics Analysis. Front Genet 2021;12:647521. [PMID: 33968130 DOI: 10.3389/fgene.2021.647521] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
21 Zou Y, Chen Z, Han H, Ruan S, Jin L, Zhang Y, Chen Z, Ma Z, Lou Q, Shi N, Jin H. Risk Signature Related to Immunotherapy Reaction of Hepatocellular Carcinoma Based on the Immune-Related Genes Associated With CD8+ T Cell Infiltration. Front Mol Biosci 2021;8:602227. [PMID: 33816550 DOI: 10.3389/fmolb.2021.602227] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
22 Song LB, Luan JC, Zhang QJ, Chen L, Wang HY, Cao XC, Song NH, Lu Y. The Identification and Validation of a Robust Immune-Associated Gene Signature in Cutaneous Melanoma. J Immunol Res 2021;2021:6686284. [PMID: 33688507 DOI: 10.1155/2021/6686284] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
23 Dessie EY, Tu SJ, Chiang HS, Tsai JJP, Chang YS, Chang JG, Ng KL. Construction and Validation of a Prognostic Gene-Based Model for Overall Survival Prediction in Hepatocellular Carcinoma Using an Integrated Statistical and Bioinformatic Approach. Int J Mol Sci 2021;22:1632. [PMID: 33562824 DOI: 10.3390/ijms22041632] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
24 Xie R, Dong S, Jiang J, Yang C, Li L, Zhao S, Li Y, Wang C, Li S, Xiao Y, Chen L. Development and Validation of an Immune-Related Gene Pair Signature in Skin Cutaneous Melanoma. Clin Cosmet Investig Dermatol 2020;13:973-86. [PMID: 33364806 DOI: 10.2147/CCID.S281364] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
25 Chen S. Identification of SARS-CoV-2 Proteins Binding Human mRNAs As a Novel Signature Predicting Overall Survival in Hepatocellular Carcinoma. DNA Cell Biol 2021;40:359-72. [PMID: 33290144 DOI: 10.1089/dna.2020.6278] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
26 Zhu R, Tao H, Lin W, Tang L, Hu Y. Identification of an Immune-Related Gene Signature Based on Immunogenomic Landscape Analysis to Predict the Prognosis of Adult Acute Myeloid Leukemia Patients. Front Oncol 2020;10:574939. [PMID: 33330048 DOI: 10.3389/fonc.2020.574939] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
27 Li JP, Li R, Liu X, Huo C, Liu TT, Yao J, Qu YQ. A Seven Immune-Related lncRNAs Model to Increase the Predicted Value of Lung Adenocarcinoma. Front Oncol 2020;10:560779. [PMID: 33163400 DOI: 10.3389/fonc.2020.560779] [Cited by in Crossref: 34] [Cited by in F6Publishing: 37] [Article Influence: 17.0] [Reference Citation Analysis]
28 Jiang S, Zhang J, Bian J, Zhang L, Xu Y, Zhao H, Sang X, Lu X. Novel nomograms based on immune and stromal scores for predicting the disease-free and overall survival of patients with hepatocellular carcinoma undergoing radical surgery. J Surg Oncol 2020;122:1569-79. [PMID: 32885449 DOI: 10.1002/jso.26197] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
29 Kang C, Jia X, Liu H. Development and validation of a RNA binding protein gene pair-associated prognostic signature for prediction of overall survival in hepatocellular carcinoma. Biomed Eng Online 2020;19:68. [PMID: 32873282 DOI: 10.1186/s12938-020-00812-0] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]